Atlas Trials

Safety Study of Gene Therapy for Ischemic Heart Disease in Korea

Clinical trial NCT01422772 · COMPLETED

Trial details

NCT number
NCT01422772
Sponsor
Helixmith Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ischemic Heart Disease
Start date
2007-01-01
Primary completion
2010-02-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.